Navigation Links
Patients with metabolic disorder may face higher complication risk following total joint replacement
Date:3/10/2014

NEW ORLEANS─In a new study presented today at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers found that total joint replacement patients with three or more metabolic syndrome risk factors were almost three times as likely to have complications within the first year after joint replacement.

Metabolic syndrome is a combination of disorders, such as obesity with a body mass index (BMI) ≥30kg/m, dyslipidemia (an abnormal amount of lipids in the blood), hypertension and diabetes. An estimated 47 million adults, ages 20 and older, and one million adolescents in the U.S. have this syndrome which increases the risk of cardiovascular disease.

The study, "Impact of Metabolic Syndrome on Peri-Operative Complication Rates after Total Joint Replacement Surgery," included 168 patients with characteristics of metabolic syndrome who underwent total hip and total knee replacements. Of the 39 patients with three or more risk factors, only 21 (16.3 percent) had complications within the first year. Obesity, measured by BMI, had the biggest impact on postoperative complications, with complications occurring in 16.2 percent of the patients with a BMI greater than 30 kg/m2. For patients with BMI below 30 kg/m2, risk for complications was only 1.6 percent. The impact of BMI becomes even greater when combined with hypertension: 30.8 percent of patients with a BMI≥30kg/m2 and hypertension experienced complications.

Identifying, counseling and addressing these issues in patients with metabolic syndrome risk factors could reduce complication rates, according to the study authors.


'/>"/>

Contact: Kristina Goel
goel@aaos.org
312-388-5241
American Academy of Orthopaedic Surgeons
Source:Eurekalert

Page: 1

Related medicine news :

1. Total hip replacement surgery safe for nonagenarian patients
2. Targeted drug may prolong survival of patients with cervical cancer
3. Investigational drug may increase survival for some patients with advanced melanoma
4. Herbal cannabis not recommended for rheumatology patients
5. New research to revolutionize healthcare through remote monitoring of patients
6. Is therapeutic hypothermia beneficial in all patients following cardiac arrest?
7. HPV-positive SCCOP patients recurrence differs from HPV-negative patients
8. Feasible, safe to limit radiation to major salivary glands in head and neck cancer patients
9. Patients with oropharyngeal cancer report quality of voice and speech affected post-treatment
10. MATH, HPV status in HNSCC patients effective markers of improved patient outcome
11. Researchers look for culprit behind oral health problems in HIV-positive patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: